Platelet-activating factor acetylhydrolase and haemophagocytosis in the sepsis syndrome

Mediators of Inflammation

Volumn 9, Issue 3-4, 2000, Pages 197-200

  Trimoreau, Franck ^a   François, Bruno ^a   Desachy, Arnaud ^a   Besse, Arnaud ^a   Vignon, Philippe ^a   Denizot, Yves ^a,b  

^a DUPUYTREN UNIVERSITY HOSPITAL   (France)

^b UNIVERSITY OF LIMOGES   (France)

Author keywords

Macrophage; Macrophagic activation; Monocyte; Multiple organ dysfunction; Platelet activating factor acetylhydrolase; Sepsis syndrome

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; COMPLEX FORMATION; ENZYME ACTIVITY; ENZYME DEGRADATION; ERYTHROPHAGOCYTOSIS; FEMALE; HUMAN; MACROPHAGE ACTIVATION; MAJOR CLINICAL STUDY; MALE; MEDIATOR RELEASE; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; REFERENCE VALUE; SEPSIS; THROMBOCYTOPENIA;

ANIMALIA;

EID: 0033672726     PISSN: 09629351     EISSN: None     Source Type: Journal    
DOI: 10.1080/09629350020002921     Document Type: Article

References (15)

1. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis
2. Platelet-activating factor: Biosynthesis, biodegradation, actions
3. Reduced PAF acetylhydrolase activity is associated with post-injury multiple organ failure
4. Platelet activating factor acetylhydrolase activity in human tissues and blood cells
5. Plasma degradation of platelet-activating factor in severely ill patients with clinical sepsis
6. Platelet-activating factor acetylhydrolase increases during macrophage differentiation
7. Human macrophages secrete platelet activating factor acetylhydrolase
8. Cellular source(s) of platelet-activating factor acetylhydrolase activity in plasma
9. Thrombocytopenia in the sepsis syndrome: Role of hemophagocytosis and macrophage colony stimulating factor
10. In vivo regulation of plasma platelet-activating factor acetylhydrolase during the acute phase response
11. APACHE II: A severity of disease classification system
12. Characterization of intensive care unit patients using a model based on the presence or absence of organ dysfunctions and/or infection: The ODIN model
13. Production, metabolism and effect of platelet-activating factor on the growth of the human K562 erythroid cell line
14. Multiple organ failure in the 1990s. Systemic inflammatory response and organ dysfunction
15. Oxygen radicals inhibit human plasma acetylhydrolase, the enzyme that catabolizes platelet activating factor